Welcome to Ir.celgene.com - Investors Home

ir.celgene.com

Description: Ir Celgene. The Investor Relations website contains information about Celgene Corporation business for stockholders, potential investors, and...

Google PR 5

Trustworthiness Good
Avg. Daily Visitors N/A

Child Safety Unknown
Avg. Daily Pageviews N/A

Privacy Good

Investors Home | Celgene Corporation

Ir.celgene.com: get to the top rated Ir Celgene pages and content popular with India-based Ir.celgene.com users or check the following digest to find out more. Ir.celgene.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Ir Celgene team are just starting to conquer the social media and they have already achieved a promising result — 1.05K user activities so far (LinkedIn dominates with around 96% of all user reactions). Ir.celgene.com is hosted with Bristol-Myers Squibb Company in United States. Ir Celgene traffic is not yet estimated by Alexa.

Visit ir.celgene.com

Domain info

Location:	United States
Registrant:	Domain Administrator (Celgene Corporation)
Hosted by:	Bristol-Myers Squibb Company
Registrar:	CSC Corporate Domains, Inc.
Subnetworks:	162.159.130.11

Social Media Activities

Facebook likes: -
Twitter mentions: 44
Google pluses: -
LinkedIn mentions: 1.01K
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Ir.celgene.com popular pages to visit

Celgene Corporation Announces 2016 Financial Outlook and Preliminary 2015 Results (NASDAQ:CELG) 2016 Guidance for Net Product Sales and Diluted EPS Preliminary 2015 Unaudited Financial Results Including Net Product Sales and Diluted EPS ...

Investor FAQs - Celgene Corporation The Investor Relations website contains information about Celgene Corporation business for stockholders, potential investors, and financial analysts.

Bristol Myers Squibb: Investor Relations Find information and tools for investors, stockholders and financial analysts, including share and dividend information, acquisition-related information, latest news and corporate reporting.